Entecavir (ETV) demonstrates consistent responses throughout baseline demographic subgroups for the treatment of nucleosidenaive, HBeAg(+) and HBeAg(-) patients with chronic hepatitis B | AVESİS

İstanbul Üniversitesi Akademik Veri Yönetim Sistemi

Entecavir (ETV) demonstrates consistent responses throughout baseline demographic subgroups for the treatment of nucleosidenaive, HBeAg(+) and HBeAg(-) patients with chronic hepatitis B

Atıf İçin Kopyala

Shouval D., Senturk H., Gish R., Chang T., Yurdaydin C., Lai C., ...Daha Fazla

40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Paris, Fransa, 13 - 17 Nisan 2005, cilt.42, ss.192

Cilt numarası: 42
Basıldığı Şehir: Paris
Basıldığı Ülke: Fransa
Sayfa Sayıları: ss.192